medigraphic.com
Colegio de Medicina Interna de México.

2023, Number 1

<< Back Next >>

Med Int Mex 2023; 39 (1)

Probability of hospitalization for chronic degenerative diseases in patients with COVID-19

Villarreal-Ríos E, Ángeles-Correa MG, Galicia-Rodríguez L, Frontana-Vázquez G, Vargas-Daza ER, Monroy-Amaro SJ, Ruiz-Pinal V, Dávalos-Álvarez J, Santibáñez-Beltrán S

Language: Spanish
References: 18
Page: 39-45
PDF size: 213.33 Kb.


ABSTRACT

Objective: To determine the probability of hospitalization for chronic degenerative disease in patients with COVID-19.
Materials and Methods: A retrospective cohort in patients with COVID-19, confirmed by RT-PCR. Two study groups were integrated, the exposed group made up of 3 subgroups, exclusively diabetes mellitus, exclusively arterial hypertension and exclusively obesity; the unexposed group was the one in which any chronic comorbidity was ruled out. Relative risk, multiple logistic regression and probability calculation of the event (hospitalization) were used.
Results: The relative risk for hospitalization in diabetes was of 3.59 (95%CI; 2.44-5.29), 3.20 (95%CI; 2.10-4.87) in hypertension and 2.56 (95%CI; 1.72-3.81) in obesity. The multiple regression equation was y = -1358 + 2388 (diabetes mellitus) + 2005 (systemic arterial hypertension) + 1458 (obesity). The probability of hospitalization when there was no chronic disease was of 20.6%, when there was a chronic disease the probability fluctuated between 52.5% and 73.5%, when there were two chronic diseases it varied from 89.1% to 95.4%, and when there were three diseases the probability of hospitalization was of 98.9%.
Conclusions: In the context of the probability of hospitalization when there is a chronic degenerative disease or it is absent, the research shows the difference in these two scenarios, as revealed by the more than 70 percentage points identified in the extreme scenarios, a condition that, led to the clinical field, reaffirms the presence of chronic degenerative disease as a risk factor for hospitalization.


REFERENCES

  1. Open database. COVID-19: casos confirmados a nivel mundialpor continente 2021. Statista; 2021. https://es.statista.com/estadisticas/1107712/covid19-casos-confirmados-anivel-mundial-por-region/.

  2. Organización Mundial de la Salud. COVID-19: Cronologíade la actuación de la OMS. OMS, 2020. http://who.int/es/news/item/27-04-2020-who-timeline---covid-19.

  3. Secretaría de Salud. Informe Técnico Diario COVID-19 MÉ-XICO. Ciudad de México: SSA, 2021. https://www.gob.mx/cms/uploads/attachment/file/689974/Comunicado_Tecnico_Diario_COVID-19_2021.12.31.pdf.

  4. Open database: Johns Hopkins University of Medicine.Coronavirus Resource Center: Mortality analyses. https://coronavirus.jhu.edu/data/mortality.

  5. Grasselli G, Pesenti A, Cecconi M. Critical care utilizationfor the COVID-19 outbreak in Lombardy, Italy: Early Experienceand forecast during an emergency response. JAMAIntern Med 2020; 323 (16): 1545-1546. doi:10.1001/jama.2020.4031

  6. Ministerio de Salud de Chile. Unidad de Gestión Centralizadade Camas, UGCC. Santiago, Chile: MINSAL; 2018.https://www.minsal.cl/wp-content/uploads/2018/03/Informe-UGCC-2014-2018.pdf.

  7. Litton E, Bucci T, Chavan S, Ho YY, Holley A, Howard G,et al. Surge capacity of intensive care units in case ofacute increase in demand caused by COVID-19 in Australia.Med J Aust 2020; 212 (10): 463-467. doi:10.5694/mja2.50596.

  8. Pan American Health Organization. COVID-19 has impactedthe operation of health services for noncommunicablediseases in the Americas. PAHO, 2020. http://paho.org/en/news/17-6-2020-covid-19-hasimpacted-operation-healthservices-noncommunicable-diseases-americas.

  9. Serra-Valdés M. Las enfermedades crónicas no transmisiblesy la pandemia por COVID-19. Revista Finlay 2020; 10(2): [aprox. 10 p].

  10. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetesis a risk factor for the progression and prognosis ofCOVID-19. Diabetes Metab Res Rev 2020; 36 (7): e3319.doi: 10.1002/dmrr.3319.

  11. Organización Mundial de la Salud; Informe de la OMS yel Foro Económico Mundial sobre un Evento Conjunto.“Prevención de las Enfermedades no Transmisibles en elLugar de Trabajo a través del Régimen Alimentario y la ActividadFísica”. World Economic Forum. Committee to Improvingthe Estate of the World. Ginebra, Suiza. 2008. https://www.who.int/dietphysicalactivity/WEFreport_spanish.pdf.

  12. Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-ÁvilaM, et al. Las enfermedades crónicas no transmisibles enMéxico: sinopsis epidemiológica y prevención integral.Salud Pública Méx 2008; 50 (5): 419-427.

  13. González-Chávez A, Elizondo-Argueta S, Gutiérrez-ReyesG, León Pedroza J. Implicaciones fisiopatológicas entreinflamación crónica y el desarrollo de diabetes y obesidad.Revista de Cirugía y Cirujanos 2011; 79 (2): 209-16.

  14. Hernández-Rodríguez J. La obesidad y la inflamacióncrónica de bajo grado. Revista Cubana de Endocrinología2018; 29 (3).

  15. Peña VH, Espinosa A. Modelamiento predictivo para elcálculo de demanda de camas hospitalarias de cuidadosintensivos a nivel nacional en el marco de la pandemia porCOVID-19. Medwave 2020; 20 (9): e8039. doi:10.5867/medwave.2020.09.8039.

  16. Benfield T, Jensen JS, Nordestgaard BG. Influencia de ladiabetes y la hiperglucemia en la hospitalización y el resultadospor enfermedades infecciosas. Diabetología 2007; 50(3): 549-554. https://doi.org/10.1007/s00125-006-0570-3.

  17. Araujo M, Ossandón P, Abarca A, Menjiba A, Muñoz A.Prognosis of patients with COVID-19 admitted to a tertiarycenter in Chile: A cohort study. Med Wave, 2020; 20 (10):e8066. doi:10.5867/medwave.2020.10.8066.

  18. Gujarati D. Econometría. 5a ed. McGraw-Hill Interamericana,2010.




2020     |     www.medigraphic.com